MR-target Biopsy vs. TRUS-biopsy in Men With Suspicious Prostate Cancer

NAUnknownINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

March 23, 2020

Primary Completion Date

April 1, 2021

Study Completion Date

April 1, 2023

Conditions
Prostate Cancer
Interventions
DEVICE

Artemia

Before prostate biopsy, all patients be preceded by mpMRI.MR-targeted biopsy using Artemis device fusion of MRI and ultrasound images would be performed. MR targeted biopsy would be performed by radiologist.

Trial Locations (1)

138-736

RECRUITING

Asan Medical Center, Seoul

Sponsors
All Listed Sponsors
collaborator

Bumjin Lim

UNKNOWN

collaborator

Dalsan Yoo

UNKNOWN

collaborator

Hyung Keun Park

UNKNOWN

collaborator

Jun Hyuk Hong

UNKNOWN

collaborator

Hanjong Ahn

UNKNOWN

collaborator

Choung-Soo Kim

UNKNOWN

collaborator

Kye Jin Park

UNKNOWN

collaborator

Mi-Hyun Kim

UNKNOWN

collaborator

Jeong Kon Kim

UNKNOWN

lead

Asan Medical Center

OTHER

NCT04320147 - MR-target Biopsy vs. TRUS-biopsy in Men With Suspicious Prostate Cancer | Biotech Hunter | Biotech Hunter